Abstract:Objective:To improve the understanding of Fabry disease by pedigree investigation and studying clinical manifestations, laboratory examination, detection ofα-galactosidase A (α-Gal A), analysis of genetic mutation as well as re-view of literatures. Methods:A proband of Fabry disease and his 21 family members underwent a family line investigation and the basic information was recorded. Urinalysis, blood cell biochemistry, α-Gal A activity in peripheral blood granulo-cytes, genetic testing, fundus examination, hearing test, skull MRI, transcranial Doppler ultrasound, ECG, echocardiography and pulmonary function tests were performed.α-Gal A activity was detected by substrate fluorescence and gene detection by PCR direct sequencing. Results:Eleven of the 21 family members were diagnosed as having Fabry disease. Results of clini-cal and laboratory examinations was not specific.α-galactosidase activity in peripheral blood granulocytes was abnormal in 6 patients and gene mutations were identified in 11 cases. Patients with different gene mutations had different clinical mani-festations. Two different sites of mutation identified in a pedigree of Fabry disease was firstly reported. Mutation was located in the 7th exon (1098delC) in 9 cases, and in 4th exon (596T>C, p.V199A) in 2 cases. The quality of life was seriously influenced in patients with classic Fabry disease, and was without any influence in patients with delayed type of disease. Conclusions:Incidence of Fabry disease in this pedigree was 52.38%(11/21);pedigree investigation should be performed to find the patients. Patients with Fabry disease lack specific clinical and laboratory manifestations, but with involvement of multiple systems, therefore, multi-system screening should be strengthened. Activity of α-Gal A is commonly abnormal in patients with classic type, while in patients with delayed type it is often normal. Gold standard for diagnosis of Fabry disease is genetic test, it is especially important for detection of female heterozygotes; Patients with different gene mutations have different clinical manifestations; Fabrydisease is not transmitted directly from father to son, if father and the son simulta neously have Fabry disease,possible causes should be investigated. Patients with classic Fabry disease have poor life quality.

[Two Novel Mutations of GLA Gene in Chinese Patients with Fabry Disease].

Novel GLA gene mutations in two Chinese families with classic Fabry disease

Genetic and Clinical Study of Three Chinese Pedigrees with Fabry Disease

Identification of a Missense Mutation in the α-galactosidase A Gene in a Chinese Family with Fabry Disease

Identification of a novel nonsense mutation in α-galactosidase A that causes Fabry disease in a Chinese family

Functional evaluation of a novel GLA causative mutation in Fabry disease.

[Pedigree Investigation of Clinicopathologic Features and Alpha-Galactosidase A Gene Mutation in a Family with Fabry Disease].

Clinical and Genetic Spectrum in Chinese Families with Fabry Disease: a Single‐centre Case Series

Genotype: A Crucial but Not Unique Factor Affecting the Clinical Phenotypes in Fabry Disease

Novel α-galactosidase A gene mutation in a Chinese Fabry disease family: A case report

A Novel Α-Galactosidase A Splicing Mutation Predisposes to Fabry Disease

Clinicopathological and genetic feathers of 14 Fabry nephropathy patients

Same genotype and different phenotypes in a Fabry disease family

GLA Variation P.e66q Identified As the Genetic Etiology of Fabry Disease Using Exome Sequencing.

c.640–814 T > C mutation in deep intronic region of alpha-galactosidase A gene is associated with Fabry disease via dominant-negative effect

Fabry's disease: clinical, pathologic and biochemical manifestations in two Chinese males

Fabry disease caused by the GLA p.Gly183Asp (p.G183D) variant: Clinical profile of a serious phenotype

GLA Mutations Suppress Autophagy and Stimulate Lysosome Generation in Fabry Disease

Report of a pedigree with Fabry disease and review of literature

Identification and Functional Characterization of the First Deep Intronic GLA Mutation (IVS4+1326C>T) Causing Renal Variant of Fabry Disease

Previously Unidentified Gene Variation Associated with Fabry Disease: The Impact on One Family